Europe Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Product Type (Instruments, Assay Kits & Consumables), By Disease Type (Systemic Autoimmune Diseases), By Technology (Immunoassays, Indirect Immunofluorescence, Multiplex Assays, Molecular Diagnostics, Point-of-Care Testing, Other Technology), By End User (Hospitals & Clinics, Clinical Laboratories, Academic & Research Institutes, Other End Users) and By Country (U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, Rest of Europ) Forecasts, 2026-2034

Last Updated: July 08, 2026 | Author: Debashree B | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Europe Autoimmune Disease Diagnostics Market Size Analysis
    1. Introduction
    2. Europe Autoimmune Disease Diagnostics Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Assay Kits & Consumables
    3. Europe Autoimmune Disease Diagnostics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Systemic Autoimmune Diseases
        1. Rheumatoid Arthritis
        2. S2 Systemic Lupus Erythematosus
        3. Scleroderma
        4. Vasculitis
        5. Inflammatory Bowel Disease
        6. Other Diseases
        7. Type 1 Diabetes
        8. Autoimmune Thyroid Diseases
    4. Europe Autoimmune Disease Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Immunoassays
      2. Indirect Immunofluorescence
      3. Multiplex Assays
      4. Molecular Diagnostics
      5. Point-of-Care Testing
      6. Other Technology
    5. Europe Autoimmune Disease Diagnostics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Clinical Laboratories
      3. Academic & Research Institutes
      4. Other End Users
  7. Europe Europe Autoimmune Disease Diagnostics Market Size Analysis
    1. Introduction
    2. Europe Autoimmune Disease Diagnostics Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Assay Kits & Consumables
    3. Europe Autoimmune Disease Diagnostics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Systemic Autoimmune Diseases
        1. Rheumatoid Arthritis
        2. S2 Systemic Lupus Erythematosus
        3. Scleroderma
        4. Vasculitis
        5. Inflammatory Bowel Disease
        6. Other Diseases
        7. Type 1 Diabetes
        8. Autoimmune Thyroid Diseases
    4. Europe Autoimmune Disease Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Immunoassays
      2. Indirect Immunofluorescence
      3. Multiplex Assays
      4. Molecular Diagnostics
      5. Point-of-Care Testing
      6. Other Technology
    5. Europe Autoimmune Disease Diagnostics Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Clinical Laboratories
      3. Academic & Research Institutes
      4. Other End Users
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
    8. France
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
    14. Rest of Europ
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      5. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
  8. Competitive Landscape
    1. Europe Autoimmune Disease Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  9. Market Players Assessment
    1. Siemens
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Grifols
    3. Trinity Biotech
    4. Werfen
    5. EUROIMMUN AG
    6. Oncimmune
    7. Seramun Diagnostica GmbH
    8. Cambridge Life Sciences Limited
    9. Menarini Diagnostics s.r.l
    10. ORGENTEC Diagnostika
    11. GROUP GMBH & CO. KG
  10. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  11. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  12. Disclaimer

We are featured on: